Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

Weitz, 2005, Colorectal cancer, Lancet, 365, 153, 10.1016/S0140-6736(05)17706-X Levine, 2006, Adenomatous polyps of the colon, N Engl J Med, 355, 2551, 10.1056/NEJMcp063038 Baron, 2003, A randomized trial of aspirin to prevent colorectal adenomas, N Engl J Med, 348, 891, 10.1056/NEJMoa021735 Sandler, 2003, A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer, N Engl J Med, 348, 883, 10.1056/NEJMoa021633 Benamouzig, 2003, Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial, Gastroenterology, 125, 328, 10.1016/S0016-5085(03)00887-4 Logan, 2008, Aspirin and folic acid for the prevention of recurrent colorectal adenomas, Gastroenterology, 134, 29, 10.1053/j.gastro.2007.10.014 Cole, 2009, Aspirin for chemoprevention of colorectal adenomas: meta-analysis of the randomised trials, J Natl Cancer Inst, 101, 256, 10.1093/jnci/djn485 Bertagnolli, 2006, Celecoxib for the prevention of sporadic colorectal adenomas, N Engl J Med, 355, 873, 10.1056/NEJMoa061355 Arber, 2006, Celecoxib for the prevention of colorectal adenomatous polyps, N Engl J Med, 355, 885, 10.1056/NEJMoa061652 Baron, 2006, A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas, Gastroenterology, 131, 1674, 10.1053/j.gastro.2006.08.079 2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71 Flossmann, 2007, Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies, Lancet, 369, 1603, 10.1016/S0140-6736(07)60747-8 Eberhart, 1994, Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas, Gastroenterology, 107, 1183, 10.1016/0016-5085(94)90246-1 Chan, 2007, Aspirin and risk of colorectal cancer in relation to expression of COX-2, N Engl J Med, 356, 2131, 10.1056/NEJMoa067208 Chan, 2009, Aspirin use and survival after diagnosis of colorectal cancer, JAMA, 302, 649, 10.1001/jama.2009.1112 Barry, 2009, Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence—data from a randomized clinical trial, Cancer Epidemiol Biomarkers Prev, 18, 2726, 10.1158/1055-9965.EPI-09-0363 Awtry, 2000, Aspirin, Circulation, 101, 1206, 10.1161/01.CIR.101.10.1206 Flossmann, 2007, Aspirin and colorectal cancer: an epidemiological success story, Int J Epidemiol, 36, 962, 10.1093/ije/dym200 Cook, 2005, Low-dose aspirin in the primary prevention of cancer: the women's health study: a randomized controlled trial, JAMA, 294, 47, 10.1001/jama.294.1.47 Stürmer, 1998, Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study, Ann Intern Med, 128, 713, 10.7326/0003-4819-128-9-199805010-00003 Kozuka, 1975, Premalignancy of the mucosal polyp in the large intestine—II: estimation of the periods required for malignant transformation of mucosal polyps, Dis Colon Rectum, 18, 494, 10.1007/BF02587218 Kelloff, 2004, Colorectal adenomas: a prototype for the use of surrogate end points in the development of cancer prevention drugs, Clin Cancer Res, 10, 3908, 10.1158/1078-0432.CCR-03-0789 1998, Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk, Lancet, 351, 233, 10.1016/S0140-6736(97)11475-1 1991, Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events, Lancet, 338, 1345, 10.1016/0140-6736(91)92233-R 1991, A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke, N Engl J Med, 325, 1261, 10.1056/NEJM199110313251801 Farrell, 1991, The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results, J Neurol Neurosurg Psychiatry, 54, 1044, 10.1136/jnnp.54.12.1044 Peto, 1988, Randomised trial of prophylactic daily aspirin in British male doctors, BMJ, 296, 313, 10.1136/bmj.296.6618.313 Wallace, 2009, The association of lifestyle and dietary factors with the risk of serrated polyps of the colorectum, Cancer Epidemiol Biomarkers Prev, 18, 2310, 10.1158/1055-9965.EPI-09-0211 Mahipal, 2006, Non-steroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa Women's Health Study, Cancer Epidemiol Biomarkers Prev, 15, 1785, 10.1158/1055-9965.EPI-05-0674 Smalley, 1999, Use of non-steroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study, Arch Intern Med, 159, 161, 10.1001/archinte.159.2.161 Friedman, 1998, Drugs and colon cancer, Pharmacoepidemiol Drug Saf, 7, 99, 10.1002/(SICI)1099-1557(199803/04)7:2<99::AID-PDS320>3.0.CO;2-0 Atkin, 2010, Once-only flexible sigmoidoscopy in prevention of colorectal cancer: a multicentre randomised controlled trial, Lancet, 375, 1624, 10.1016/S0140-6736(10)60551-X Juul-Moller, 1992, Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris, Lancet, 340, 1421, 10.1016/0140-6736(92)92619-Q van Wijk, 2005, Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study, Lancet, 365, 2098, 10.1016/S0140-6736(05)66734-7 Fasey, 2002, Thrombosis prevention trial: follow-up study of practical implications, Br J Gen Pract, 52, 208 Brewster, 2002, Reliability of cancer registration data in Scotland, 1997, Eur J Cancer, 38, 414, 10.1016/S0959-8049(01)00385-9 Hawkins, 1992, Completeness of cancer and death follow-up obtained through the National health Service Central Register for England and Wales, Br J Cancer, 66, 408, 10.1038/bjc.1992.279 Brewster, 1995, Registration of colorectal cancer in Scotland: an assessment of data accuracy based on review of medical records, Public Health, 109, 285, 10.1016/S0033-3506(95)80206-1 Pollock, 1995, Reliability of data of the Thames cancer registry on 673 cases of colorectal cancer: effect of the registration process, Qual Health Care, 4, 184, 10.1136/qshc.4.3.184 Elsaleh, 2000, Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer, Lancet, 355, 1745, 10.1016/S0140-6736(00)02261-3 Bufill, 1990, Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumour location, Ann Intern Med, 113, 779, 10.7326/0003-4819-113-10-779 Iacopetta, 2002, Are there two sides to colorectal cancer?, Int J Cancer, 101, 403, 10.1002/ijc.10635 Birkenkamp-Demtroder, 2005, Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid, Gut, 54, 374, 10.1136/gut.2003.036848 Leopoldo, 2008, Two types of mucinous adenocarcinoma of the colorectum: clinicopathological and genetic features, Ann Surg Oncol, 15, 1429, 10.1245/s10434-007-9757-1 Chapple, 2000, Localisation of cyclooxygenase-2 in human sporadic colorectal adenomas, Am J Pathol, 156, 545, 10.1016/S0002-9440(10)64759-1 Nasir, 2004, Cyclooxygenase-2 expression in right- and left-sided colon cancer: a rationale for optimisation of cyclooxygenase-2 inhibitor therapy, Clin Colorectal Cancer, 3, 243, 10.3816/CCC.2004.n.005 Ederer, 1999, Colorectal cancer deaths as determined by expert committee and from death certificate: a comparison—The Minnesota Study, J Clin Epidemiol, 52, 447, 10.1016/S0895-4356(99)00016-5 2009, Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials, Lancet, 373, 1849, 10.1016/S0140-6736(09)60503-1 Greving, 2008, Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk, Circulation, 117, 2875, 10.1161/CIRCULATIONAHA.107.735340 Regula, 2006, Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia, N Engl J Med, 355, 1863, 10.1056/NEJMoa054967 Abela, 2009, Cancer of the proximal colon after a “normal” colonoscopy, Biosci Trends, 3, 158 Bedenne, 1992, Adenoma—carcinoma sequence or “de novo” carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers, Cancer, 69, 883, 10.1002/1097-0142(19920215)69:4<883::AID-CNCR2820690408>3.0.CO;2-B